BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25044148)

  • 1. A prognostic model including pre- and postsurgical variables to enhance risk stratification of primary mediastinal nonseminomatous germ cell tumors: the 27-year experience of a referral center.
    Necchi A; Giannatempo P; Lo Vullo S; Farè E; Raggi D; Marongiu M; Scanagatta P; Duranti L; Giovannetti R; Girelli L; Nicolai N; Piva L; Biasoni D; Torelli T; Catanzaro M; Stagni S; Maffezzini M; Gianni AM; Mariani L; Pastorino U; Salvioni R
    Clin Genitourin Cancer; 2015 Feb; 13(1):87-93.e1. PubMed ID: 25044148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center.
    Sarkaria IS; Bains MS; Sood S; Sima CS; Reuter VE; Flores RM; Motzer RJ; Bosl GJ; Rusch VW
    J Thorac Oncol; 2011 Jul; 6(7):1236-41. PubMed ID: 21610519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
    Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
    Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.
    Kang CH; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Feb; 85(2):379-84. PubMed ID: 18222229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of primary malignant germ cell tumor of the mediastinum.
    Sakurai H; Asamura H; Suzuki K; Watanabe S; Tsuchiya R
    Jpn J Clin Oncol; 2004 Jul; 34(7):386-92. PubMed ID: 15342665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with primary mediastinal germ cell tumors, a surgical multicenter retrospective study.
    Rivera C; Arame A; Jougon J; Velly JF; Begueret H; Dahan M; Riquet M
    Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):585-9. PubMed ID: 20709694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
    Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C
    Ann Oncol; 2016 May; 27(5):875-9. PubMed ID: 26861605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of primary mediastinal germ cell tumors].
    Zhou JF; Bai CM; Yang D; Chen SC
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):531-4. PubMed ID: 18069635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
    Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C
    Clin Genitourin Cancer; 2017 Apr; 15(2):306-312.e3. PubMed ID: 27594554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
    Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
    J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
    Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery.
    Kesler KA; Brooks JA; Rieger KM; Fineberg NS; Einhorn LH; Brown JW
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):913-23. PubMed ID: 12698156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mediastinal nonseminomatous germ cell tumors. Results of a multimodality approach.
    Wright CD; Kesler KA; Nichols CR; Mahomed Y; Einhorn LH; Miller ME; Brown JW
    J Thorac Cardiovasc Surg; 1990 Feb; 99(2):210-7. PubMed ID: 2153877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single institution, retrospective study of treatment experience in primary mediastinal germ cell tumors: elucidating the significance of systemic chemotherapy.
    Wang JL; Yu H; Guo Y; Hu XC; Pan ZQ; Chang JH; Zhang YW
    Chin Med J (Engl); 2012 Feb; 125(4):626-30. PubMed ID: 22490486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.